- AUD/USD fails to holds onto recovery gains.
- Coronavirus updates renew the US dollar buying amid fears of widespread contagion.
- PBOC rate decision can offer intermediate moves, Remdesivir, COVID-19 will keep the driver’s seat.
AUD/USD extends the pullback from 0.5900 while declining to 0.5725 at the start of Friday’s Asian session. While efforts from the US Fed to shore the US dollar supplies dragged the greenback earlier, fresh coronavirus (COVID-19) updates help it regain the strength.
Global central banks continue to fight against COVID-19…
Be it the RBA, ECB, BOJ or the Fed, not to forget the BOE and Asian banks, all at the helm keep pumping their respective monetary system and or avail swaps to fight against the deadly virus.
The RBA’s 25 basis points (bps) rate cut and a QE seemed to have escalated the market’s worries the previous day. “The RBA cut the cash rate 0.25% yesterday and announced that they would target the 3-year ACGB rate at 0.25% and buy bonds in unlimited volume ‘across the yield curve’. Unfortunately, the market didn’t get the last part of that message straight away and hit the panic button, with the 10-year Australian Government bond yield rising over 100bps in less than a minute,” said the Australia and New Zealand Banking Group (ANZ).
On the other hand, the Fed makes swap arrangements with nine more central banks to cut the USD shortage at the time of the market’s rush to hoard the greenback.
In the case of coronavirus updates, NYC Mayor De Blasio recently signaled the shortage of medical supplies in 2-3 weeks while seeking military help to fight the pandemic. Further, news that the Brexit negotiators of the UK and the EU are both infected with the deadly virus has also renewed the risk-off.
As a result, Wall Street’s mildly positive closing fails to carry the mark on the US 10-year treasury yields that are down one basis point to 1.158%.
Given the lack of major data/events on the economic calendar, except for the People’s Bank of China’s (PBOC) rate decision, investors will keep eyes on the disease updates. News that a cure has been tested, Remdesivir, gives the hope to overcome the pandemic.
Technical Analysis
A descending trend line connecting lows marked between March 09 and 16 offers immediate resistance around 0.5950. On the downside, 0.5600 and the recent low near 0.5510 will please sellers during further downside.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD alternates gains with losses near 1.0720 post-US PCE
The bullish tone in the Greenback motivates EUR/USD to maintain its daily range in the low 1.070s in the wake of firmer-than-estimated US inflation data measured by the PCE.
GBP/USD clings to gains just above 1.2500 on US PCE
GBP/USD keeps its uptrend unchanged and navigates the area beyond 1.2500 the figure amidst slight gains in the US Dollar following the release of US inflation tracked by the PCE.
Gold keeps its daily gains near $2,350 following US inflation
Gold prices maintain their constructive bias around $2,350 after US inflation data gauged by the PCE surpassed consensus in March and US yields trade with slight losses following recent peaks.
Bitcoin Weekly Forecast: BTC’s next breakout could propel it to $80,000 Premium
Bitcoin’s recent price consolidation could be nearing its end as technical indicators and on-chain metrics suggest a potential upward breakout. However, this move would not be straightforward and could punish impatient investors.
Week ahead – Hawkish risk as Fed and NFP on tap, Eurozone data eyed too
Fed meets on Wednesday as US inflation stays elevated. Will Friday’s jobs report bring relief or more angst for the markets? Eurozone flash GDP and CPI numbers in focus for the Euro.